Maynard Um
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) PT Lowered to $11 at H.C. Wainwright
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) files mixed shelf
-
-
-
-
-
-
-
Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026
-
-
-
-
-
-
-
Barclays Starts CytomX Therapeutics (CTMX) at Overweight
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) Tops Q1 EPS by 21c
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) Tops Q3 EPS by 24c
-
-
-
-
-
-
470,301 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


